OncoMed Pharmaceuticals Inc Proceeds from Common Stock Issued
OncoMed Pharmaceuticals Inc reported Proceeds from Common Stock Issued of $63.91 million for the 9-month period ending 2016-09-30, per its 10-Q filed 2017-11-02.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfCommonStock · last filed 2017-11-02
- OncoMed Pharmaceuticals Inc proceeds from issuance of common stock for the quarter ending 2016-09-30 was $62.98M.
- OncoMed Pharmaceuticals Inc proceeds from issuance of common stock for fiscal 2013 was $20.52M.
| Period end | Proceeds from Issuance of Common Stock 3 month | Proceeds from Issuance of Common Stock 6 month | Proceeds from Issuance of Common Stock 9 month | Proceeds from Issuance of Common Stock 12 month |
|---|---|---|---|---|
| 2016-09-30 | $62.98M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | $63.91M 10-Q · filed 2017-11-02 | ||
| 2016-06-30 | $934.00K 10-Q · filed 2017-08-02 | |||
| 2013-12-31 | $20.52M 10-K · filed 2016-03-10 | |||
| 2013-06-30 | $17.00K 10-Q · filed 2013-09-03 | |||
| 2012-06-30 | $123.00K 10-Q · filed 2013-09-03 |